ATE294236T1 - Promotor der tie rezeptor protein kinase - Google Patents
Promotor der tie rezeptor protein kinaseInfo
- Publication number
- ATE294236T1 ATE294236T1 AT95931236T AT95931236T ATE294236T1 AT E294236 T1 ATE294236 T1 AT E294236T1 AT 95931236 T AT95931236 T AT 95931236T AT 95931236 T AT95931236 T AT 95931236T AT E294236 T1 ATE294236 T1 AT E294236T1
- Authority
- AT
- Austria
- Prior art keywords
- promoter
- protein kinase
- receptor protein
- tie receptor
- tie
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31071794A | 1994-09-22 | 1994-09-22 | |
PCT/FI1995/000520 WO1996009381A1 (en) | 1994-09-22 | 1995-09-22 | Promoter for the receptor tyrosine kinase, tie |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE294236T1 true ATE294236T1 (de) | 2005-05-15 |
Family
ID=23203808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95931236T ATE294236T1 (de) | 1994-09-22 | 1995-09-22 | Promotor der tie rezeptor protein kinase |
Country Status (8)
Country | Link |
---|---|
US (1) | US5877020A (de) |
EP (1) | EP0783572B1 (de) |
JP (1) | JPH10506011A (de) |
AT (1) | ATE294236T1 (de) |
AU (1) | AU701568B2 (de) |
DE (1) | DE69534180T2 (de) |
NO (1) | NO971341L (de) |
WO (1) | WO1996009381A1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2756570B1 (fr) | 1996-12-03 | 2002-09-27 | Commissariat Energie Atomique | Promoteur de la ve-cadherine et ses utilisations |
US6350450B1 (en) | 1997-09-19 | 2002-02-26 | Genentech, Inc. | TIE ligand homologue antibody |
US5972338A (en) | 1997-09-19 | 1999-10-26 | Genentech, Inc. | Tie ligands homologues |
US6057435A (en) | 1997-09-19 | 2000-05-02 | Genentech, Inc. | Tie ligand homologues |
US6030831A (en) * | 1997-09-19 | 2000-02-29 | Genetech, Inc. | Tie ligand homologues |
US6348350B1 (en) | 1997-09-19 | 2002-02-19 | Genentech, Inc. | Ligand homologues |
US6130207A (en) * | 1997-11-05 | 2000-10-10 | South Alabama Medical Science Foundation | Cell-specific molecule and method for importing DNA into a nucleus |
WO2001072339A2 (en) * | 2000-03-30 | 2001-10-04 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Method of treatment of conditions involving obstruction of blood flow |
JP2004517080A (ja) * | 2000-11-29 | 2004-06-10 | グラクソ グループ リミテッド | Tie−2および/またはvegfr−2の阻害剤として有用なベンゾイミダゾール誘導体 |
US20090181092A1 (en) * | 2004-07-16 | 2009-07-16 | Spinal Restoration, Inc. | Methods for Treating Joints and Discs with a Carrier Matrix and Cells |
GB0423554D0 (en) * | 2004-10-22 | 2004-11-24 | Cancer Rec Tech Ltd | Therapeutic compounds |
GB0428082D0 (en) * | 2004-12-22 | 2005-01-26 | Welcome Trust The Ltd | Therapeutic compounds |
US7951819B2 (en) | 2006-04-26 | 2011-05-31 | Cancer Research Technology Limited | Imidazo[4, 5-B]pyridin-2-one and oxazolo[4, 5-B] pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds |
CA2715080C (en) | 2007-09-28 | 2021-09-28 | Intrexon Corporation | Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof |
BRPI0821227A2 (pt) * | 2007-12-19 | 2015-06-16 | Cancer Rec Tech Ltd | Composto, composição farmacêutica, método para preparar a mesma, uso de um composto, método para tratar uma doença ou distúrbio, para inibir função de raf e para inibir proliferação celular, inibir progressão do ciclo celular, promover apoptose, ou uma combinação de um ou mais dos mesmos |
GB0807609D0 (en) * | 2008-04-25 | 2008-06-04 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
AU2011209586B2 (en) | 2010-02-01 | 2016-01-21 | Cancer Research Technology Limited | 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro- 4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo [4,5-b]pyridin-7-yloxy)-phenyl] -urea and related compounds and their use in therapy |
EP2956159A1 (de) | 2013-02-14 | 2015-12-23 | UCL Business Plc. | Mittel zur induzierung von lymphangiogenese zur verwendung bei der behandlung von zystennierenerkrankungen |
GB201320729D0 (en) | 2013-11-25 | 2014-01-08 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
GB201320732D0 (en) | 2013-11-25 | 2014-01-08 | Cancer Rec Tech Ltd | Methods of chemical synthesis |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07506242A (ja) * | 1992-01-09 | 1995-07-13 | ヘルシンキ ユニバーシティ ホルディング リミテッド | Tie,新規内皮細胞受容体チロシンキナーゼ |
US5466596A (en) * | 1992-08-25 | 1995-11-14 | Mount Sinai Hospital Corporation | Tissue specific transcriptional regulatory element |
-
1995
- 1995-09-22 EP EP95931236A patent/EP0783572B1/de not_active Expired - Lifetime
- 1995-09-22 AT AT95931236T patent/ATE294236T1/de not_active IP Right Cessation
- 1995-09-22 JP JP8510638A patent/JPH10506011A/ja active Pending
- 1995-09-22 DE DE69534180T patent/DE69534180T2/de not_active Expired - Fee Related
- 1995-09-22 WO PCT/FI1995/000520 patent/WO1996009381A1/en active IP Right Grant
- 1995-09-22 AU AU34748/95A patent/AU701568B2/en not_active Ceased
-
1996
- 1996-05-31 US US08/650,598 patent/US5877020A/en not_active Expired - Fee Related
-
1997
- 1997-03-21 NO NO971341A patent/NO971341L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0783572B1 (de) | 2005-04-27 |
NO971341D0 (no) | 1997-03-21 |
NO971341L (no) | 1997-05-14 |
DE69534180D1 (de) | 2005-06-02 |
DE69534180T2 (de) | 2006-03-02 |
AU3474895A (en) | 1996-04-09 |
AU701568B2 (en) | 1999-02-04 |
EP0783572A1 (de) | 1997-07-16 |
WO1996009381A1 (en) | 1996-03-28 |
JPH10506011A (ja) | 1998-06-16 |
US5877020A (en) | 1999-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69534180D1 (de) | Promotor der tie rezeptor protein kinase | |
DE69434538D1 (de) | Vaskularer endothelialer wachstumsfaktor 2 | |
DE69837996D1 (de) | Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta | |
DE68929043T2 (de) | Für androgen-rezeptor-protein kodierende dna | |
DE69836131D1 (de) | Neue menschliche delta3-zusammensetzung und deren therapeutische und diagnostische verwendungen | |
DE69726741D1 (de) | Verwendungen von angiogenischer factor vegf145 in der behandlung von kardiovaskulaeren krankheiten | |
DE69434926D1 (de) | Menschlicher gewebsinhibitor von metalloproteinase-4 | |
DK1007537T3 (da) | Receptor-protein med betegnelsen 2F1 | |
ATE396205T1 (de) | Die verwendung von peptiden von il-2 und peptid- derivaten als therapeutische wirkstoffe | |
IS2819B (is) | Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra | |
EA200100264A1 (ru) | Ангиоцидин: адгезионный рецептор опухолей клетки, специфический для cys-ser-val-thr-cys-gly | |
ATE303439T1 (de) | Intrazelluläre isoform von interleukin-1 rezeptor antagonist | |
BR9908096A (pt) | Proteìna 3 da zona pelúcida humana (hzp3), ativa, recombinante | |
NO961423D0 (no) | Oligopeptider avledet fra C-reaktive proteinfragmenter | |
DK0939769T3 (da) | Vertebrat-Smoothened-proteiner | |
TR200000416T2 (tr) | Neisseria loctoferrin bağlayıcı protein. | |
DE59708511D1 (de) | Verwendung von 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen | |
BR0012704A (pt) | Anticorpos antitumor, proteìnas e usos dos mesmos | |
DE59805246D1 (de) | Tissue-faktor zur beeinflussung von gefässbildung | |
DE69712182D1 (de) | Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises | |
DE69821227D1 (de) | Verwendung von papovavirus kapsid-proteinen zur verabreichung therapeutischen agentien in nervzellen | |
CA2200846A1 (en) | Promoter for the receptor tyrosine kinase, tie | |
ATE362531T1 (de) | Interne ribosom eintrittstelle (ires), vektor der diesen enthaltet und dessen therapeutische verwendung | |
IT1299201B1 (it) | Fibroblasti modificati geneticamente e loro uso | |
DK0542869T3 (da) | Vævsplasminogenaktivatorvarianter med nedsat udskillelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0783572 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |